The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 37, No. 9, pp. 1224-1227. DOI 10.1345/aph.1C516
© 2003 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dogu, O.
Right arrow Articles by Kaleagasi, H. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dogu, O.
Right arrow Articles by Kaleagasi, H. S

Seizures Associated with Quetiapine Treatment

Okan Dogu, MD

Assistant Professor of Neurology, Department of Neurology, Faculty of Medicine, Mersin University, Mersin, Turkey

Serhan Sevim, MD

Assistant Professor of Neurology, Department of Neurology, Faculty of Medicine, Mersin University

Hakan S Kaleagasi, MD

Senior Resident, Department of Neurology, Faculty of Medicine, Mersin University

Reprints: Okan Dogu MD, Mersin Universitesi Hastanesi, Noroloji AD. Zeytinlibahce cad. Mersin 33070, Turkey, FAX 90 324 3374305, okandogu{at}mersin.edu.tr

OBJECTIVE: To report a case of seizures in a patient with Alzheimer disease, who was receiving quetiapine for psychoses.

CASE SUMMARY: A 75-year-old white man with Alzheimer disease was observed to have seizures while receiving quetiapine 500 mg/d and carbamazepine 200 mg/d. He had been taking quetiapine for 18 months prior to the event. No other toxic, metabolic, or anatomic abnormalities were identified to explain the seizures. After cessation of quetiapine treatment, the patient remained seizure free. An objective causality assessment revealed that the adverse drug reaction was possible.

DISCUSSION: The patient was taking a relatively high dose of quetiapine. An increased risk of seizures has been associated with Alzheimer disease. Using a relatively high dose of quetiapine may have resulted in seizures in our patient with Alzheimer disease.

CONCLUSIONS: As with other antipsychotics, quetiapine should be used cautiously in elderly patients with conditions that can lower the seizure threshold, and special monitoring should be performed for this serious adverse effect.

Key Words: Alzheimer disease, quetiapine, seizure

Published Online, June 16, 2003. www.theannals.com, DOI 10.1345/aph.1C516


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
A. Precourt, M. Dunewicz, G. Gregoire, and D. R Williamson
Multiple Complications and Withdrawal Syndrome Associated with Quetiapine/Venlafaxine Intoxication
Ann. Pharmacother., January 1, 2005; 39(1): 153 - 156.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2003 by Harvey Whitney Books Company.